AMNEAL PHARMACEUTICALS, INC. Unrecognized Tax Benefits that Would Impact Effective Tax Rate
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Unrecognized Tax Benefits that Would Impact Effective Tax Rate of $4.00 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate · last filed 2026-02-27
- 2025-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $4.00M.
- 2024-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $3.90M.
- 2023-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $3.70M; Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed $3.60M.
- 2022-12-31: Unrecognized Tax Benefits that Would Impact Effective Tax Rate $3.50M.
| Period end | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate as first filed |
|---|---|---|
| 2025-12-31 | $4.00M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $3.90M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $3.70M 10-K · filed 2026-02-27 | $3.60M 10-K · filed 2024-03-14 |
| 2022-12-31 | $3.50M 10-K · filed 2025-02-28 | |
| 2021-12-31 | $5.40M 10-K · filed 2024-03-14 | $5.00M 10-K · filed 2022-03-01 |
| 2020-12-31 | $5.00M 10-K · filed 2023-03-03 | |
| 2019-12-31 | $6.00M 10-K · filed 2022-03-01 | |
| 2018-12-31 | $7.00M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |